Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05093842 · ClinicalTrials.gov registry record · NA
Sedentary Behavior Reduction in Pregnancy Intervention Study
A NA study of Sedentary Behavior and Pregnancy Complications, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 1
- Study location
NCT05093842: Completed NA study of Sedentary Behavior and Pregnancy Complications, sponsored by University of Pittsburgh.
NCT05093842 is a NA study of Sedentary Behavior and Pregnancy Complications that has completed, run by University of Pittsburgh. The registered enrollment target is 51 participants, below the 756-participant average among 42 other Sedentary Behavior trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05093842, a NA study of Sedentary Behavior and Pregnancy Complications, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot and feasibility study will enroll newly pregnant women at risk for high sedentary behavior (SED) and elevated APO risk (n=53) and will randomize them to either a SED reduction intervention or control. Research aims include to: 1) demonstrate our ability to decrease SED and increase standing and light activity in pregnant women; 2) evaluate feasibility; and 3) gather preliminary effects on clinical outcomes including APOs, cardiometabolic risk factors, well-being, and fetal outcomes.
Primary Outcome
objectively measured using activPAL3 micro
Conditions Studied
Interventions
- BEHAVIORAL Sedentary Behavior Reduction
- BEHAVIORAL Information on Physical Activity Recommendations during Pregnancy
Study Locations (1)
Pennsylvania
- University of Pittsburgh, Department of Health and Human Development, 32 Oak Hill Court, Room 220 - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2021-10-04 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
What the finished NCT05093842 record still lists
NCT05093842 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 756-participant average among 42 other Sedentary Behavior trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Sedentary Behavior appearing as the primary indexed condition, and to 2 interventions - of which Sedentary Behavior Reduction is the first listed.
NCT05093842 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05093842 about?
NCT05093842 is a clinical study titled "Sedentary Behavior Reduction in Pregnancy Intervention Study". This pilot and feasibility study will enroll newly pregnant women at risk for high sedentary behavior (SED) and elevated APO risk (n=53) and will randomize them to either a SED reduction intervention or control. Research aims include to: 1) demonstrate our ability to decrease SED and increase standi...
What is the current status of trial NCT05093842?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2021-10-04. Estimated completion is 2023-06-30.
What conditions does trial NCT05093842 study?
This clinical trial studies the following conditions: Sedentary Behavior, Pregnancy Complications.
What interventions are being tested in trial NCT05093842?
The interventions under investigation include: Sedentary Behavior Reduction (BEHAVIORAL), Information on Physical Activity Recommendations during Pregnancy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05093842?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05093842 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sedentary Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05093842's enrollment target sits among peer trials
51 29th of 42 higher than 14 of 42 other Sedentary Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sedentary Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Teen Mom Study Feasibility Trial
RECRUITING · NA
-
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
RECRUITING · NA
-
Promoting Physical Activity in Older Hispanic/Latino(a) Adults
RECRUITING · NA
-
Sitting Interruption and Whole-body Cardiovascular Health
RECRUITING · NA
-
The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI